See also this year's filing and all EDGAR filings for this company.
PDF Report 0001799191_2026_Oncology_Institute_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.17278589187022708, 'aggregate_val': 538681000, 'exp_sum': 651199000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 105574000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 538812000, 'DepreciationDepletionAndAmortization': 6944000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': -131000}} |
Graph
Absolute values for 0001799191, Oncology Institute Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 18,245,000 |
| 1 | AssetsNonCurrent | 22,980,000 |
| 2 | AssetsCurrent | 112,747,000 |
| 3 | PropertyPlantAndEquipment | 10,684,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 96,559,000 |
| 6 | LiabilitiesCurrent | 70,962,000 |
| 7 | remainder_Liabilities | 12,855,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 105,574,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 538,812,000 |
| 13 | DepreciationDepletionAndAmortization | 6,944,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -112,649,000 |
| 17 | remainder_Revenues | 502,729,000 |
| 18 | remainder_NetIncome | -24,654,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 164,656,000 |
| 1 | Liabilities | 180,376,000 |
| 2 | Expenses | 538,681,000 |
| 3 | Revenues | 502,729,000 |
| 4 | StockholdersEquity | -15,720,000 |
| 5 | NetIncome | -60,606,000 |
| 6 | ComprehensiveNetIncome | -60,606,000 |
| 7 | BaseVar | 705,548,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.483 |
| 9 | EconomicCapitalRatio | 0.833 |
Edgar->Model Mapping
Feature Distribution
Change over Time
